Eyes on Novartis shares as Alcon deal nears close

deal is done, and analysts see upside to the Novartis stock thanks to recently launched products like oral multiple sclerosis pill Gilenya, its solid pipeline and potentially strong first quarter results on April 19. THE ONLY WAY IS UP At 1138 GMT,...